2007
DOI: 10.1111/j.1432-2277.2007.00572.x
|View full text |Cite
|
Sign up to set email alerts
|

Salvage live donor liver transplantation for a second recurrence of hepatocellular carcinoma

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2009
2009
2009
2009

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 23 publications
0
1
0
Order By: Relevance
“…Since the first report in 1989, living donor liver transplantation (LDLT) has been gradually accepted as a therapeutic modality for end‐stage liver cirrhosis and hepatocellular carcinoma [1–3]. The decision of the choice between the right lobe and extended left lobe depends on the physical constitution of the recipient in LDLT [4,5].…”
Section: Introductionmentioning
confidence: 99%
“…Since the first report in 1989, living donor liver transplantation (LDLT) has been gradually accepted as a therapeutic modality for end‐stage liver cirrhosis and hepatocellular carcinoma [1–3]. The decision of the choice between the right lobe and extended left lobe depends on the physical constitution of the recipient in LDLT [4,5].…”
Section: Introductionmentioning
confidence: 99%